Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-01-03 Sale | 2022-01-05 5:35 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 3,800 | $23.07 | $87,666 | 86,822 (Direct) | View |
| 2021-12-01 Sale | 2021-12-03 6:15 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $24.44 | $139,330 | 90,622 (Direct) | View |
| 2021-11-01 Sale | 2021-11-03 6:05 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $24.03 | $136,956 | 194,544 (Direct) | View |
| 2021-10-01 Sale | 2021-10-04 5:51 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $24.83 | $141,506 | 102,022 (Direct) | View |
| 2021-09-01 Sale | 2021-09-02 6:30 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $26 | $148,223 | 107,722 (Direct) | View |
| 2021-08-02 Sale | 2021-08-04 7:41 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $28.87 | $164,554 | 113,422 (Direct) | View |
| 2021-07-13 Sale | 2021-07-15 7:29 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 43,166 | $32.75 | $1,413,654 | 130,895 (Direct) | View |
| 2021-07-01 Sale | 2021-07-02 5:41 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $33.33 | $189,987 | 119,122 (Direct) | View |
| 2021-06-01 Sale | 2021-06-03 5:48 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 575 | $39.43 | $22,669 | 124,822 (Direct) | View |
| 2020-12-28 Sale | 2021-03-04 5:00 pm | Stoke Therapeutics Inc. | STOK | Liau Gene VP | 5,344 | $62.93 | $336,297 | 233,094 (Direct) | View |
| 2021-03-01 Sale | 2021-03-03 5:10 pm | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 12,500 | $60.79 | $759,841 | 26,743 (Indirect Direct) | View |
| 2021-02-22 Sale | 2021-02-24 5:15 pm | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 30,000 | $58.86 | $1,765,896 | 365,596 (Direct) | View |
| 2021-02-19 Sale | 2021-02-23 5:28 pm | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 10,000 | $60.67 | $606,652 | 13,447 (Direct) | View |
| 2021-01-04 Sale | 2021-01-06 5:26 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,732 | $58.96 | $337,985 | 125,397 (Direct) | View |
| 2020-12-21 Sale | 2020-12-21 4:53 pm | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 1,365 | $57.62 | $78,654 | 257,802 (Direct) | View |
| 2020-12-17 Sale | 2020-12-18 9:08 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 50,000 | $60 | $3,000,000 | 352,757 (Direct) | View |
| 2020-12-17 Sale | 2020-12-18 9:07 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 25,000 | $60 | $1,500,000 | 0 (Direct) | View |
| 2020-12-01 Sale | 2020-12-03 6:00 pm | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $49.84 | $284,080 | 131,097 (Direct) | View |
| 2020-11-27 Sale | 2020-11-30 5:11 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 12,152 | $50 | $607,600 | 25,000 (Direct) | View |
| 2020-11-25 Sale | 2020-11-25 5:16 pm | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 12,848 | $50 | $642,400 | 37,152 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-03-15 Option Award | 2022-03-17 5:19 pm | N/A 2032-03-14 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 308,000 | $0 | 308,000 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 5:17 pm | N/A 2032-03-14 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 107,400 | $0 | 107,400 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 5:15 pm | N/A 2032-03-14 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 107,400 | $0 | 107,400 (Direct) | View |
| 2022-03-15 Option Award | 2022-03-17 5:13 pm | N/A 2032-03-14 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 107,400 | $0 | 107,400 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 5:35 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 3,800 | $2.19 | 86,822 (Direct) | View |
| 2022-01-03 Exercise | 2022-01-05 5:35 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 3,800 | $0 | 86,822 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 6:15 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 90,622 (Direct) | View |
| 2021-12-01 Exercise | 2021-12-03 6:15 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 90,622 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 6:05 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 194,544 (Direct) | View |
| 2021-11-01 Exercise | 2021-11-03 6:05 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 194,544 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-04 5:51 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 102,022 (Direct) | View |
| 2021-10-01 Exercise | 2021-10-04 5:51 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 102,022 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 6:30 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 107,722 (Direct) | View |
| 2021-09-01 Exercise | 2021-09-02 6:30 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 107,722 (Direct) | View |
| 2021-08-02 Exercise | 2021-08-04 7:41 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 113,422 (Direct) | View |
| 2021-08-02 Exercise | 2021-08-04 7:41 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 113,422 (Direct) | View |
| 2021-07-01 Exercise | 2021-07-02 5:41 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 119,122 (Direct) | View |
| 2021-07-01 Exercise | 2021-07-02 5:41 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 119,122 (Direct) | View |
| 2021-06-28 Other | 2021-06-30 4:32 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | ATP Life Science Ventures L.P. ATP III GP Ltd. 10% Owner | 17,161,713 | $0 | 17,161,713 (Direct) | View |
| 2021-06-21 Ownership | 2021-06-30 4:14 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Skorpios Trust Blue Horizon Enterprise Ltd Ezbon International Ltd Montrago Trustees Ltd 10% Owner | 0 | $0 | 14,443,681 (Indirect) | View |
| 2021-06-08 Option Award | 2021-06-25 5:04 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 5:02 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Smith Julie Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 5:01 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 5:00 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 4:58 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Krainer Adrian R. Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 4:57 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Harrison Seth Loring Director 10% Owner | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-08 Option Award | 2021-06-25 4:56 pm | N/A 2031-06-07 | Stoke Therapeutics Inc. | STOK | Burstein Jennifer Director | 11,650 | $0 | 11,650 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 5:48 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 575 | $2.19 | 124,822 (Direct) | View |
| 2021-06-01 Exercise | 2021-06-03 5:48 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 575 | $0 | 124,822 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 5:04 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 65,600 | $0 | 65,600 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 5:03 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 65,600 | $0 | 239,231 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 5:01 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 65,600 | $0 | 65,600 (Direct) | View |
| 2020-12-28 Exercise | 2021-03-04 5:00 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Liau Gene VP | 13,195 | $0.6 | 233,094 (Direct) | View |
| 2020-12-28 Exercise | 2021-03-04 5:00 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Liau Gene VP | 13,195 | $0 | 233,094 (Direct) | View |
| 2020-12-28 Option Award | 2021-03-04 5:00 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Liau Gene VP | 40,800 | $0 | 233,094 (Direct) | View |
| 2021-03-02 Option Award | 2021-03-04 4:57 pm | N/A 2031-03-01 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 200,800 | $0 | 200,800 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 5:10 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 7,882 | $0.6 | 26,743 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 5:10 pm | N/A 2026-02-11 | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 12,500 | $0 | 26,743 (Direct) | View |
| 2021-03-01 Exercise | 2021-03-03 5:10 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | LEVIN ARTHUR A Director | 4,618 | $0.4 | 26,743 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-24 5:15 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 30,000 | $4.48 | 365,596 (Direct) | View |
| 2021-02-22 Exercise | 2021-02-24 5:15 pm | N/A 2029-03-18 | Stoke Therapeutics Inc. | STOK | Tulipano Stephen J CFO | 30,000 | $0 | 365,596 (Direct) | View |
| 2021-02-19 Exercise | 2021-02-23 5:28 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 10,000 | $2.19 | 13,447 (Direct) | View |
| 2021-02-19 Exercise | 2021-02-23 5:28 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | TZIANABOS ARTHUR Director | 10,000 | $0 | 13,447 (Direct) | View |
| 2020-08-13 Option Award | 2021-01-27 5:19 pm | N/A 2030-08-13 | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 29,555 | $0 | 29,555 (Direct) | View |
| 2020-08-13 Ownership | 2021-01-27 5:17 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Menzel Garry E Director | 0 | $0 | 0 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 5:26 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 125,397 (Direct) | View |
| 2021-01-04 Exercise | 2021-01-06 5:26 pm | N/A 2018-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 125,397 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 6:33 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 10,000 | $0.6 | 647,801 (Direct) | View |
| 2020-12-30 Exercise | 2021-01-04 6:33 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Kaye Edward M. MD CEO | 10,000 | $0 | 647,801 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-21 4:53 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 1,365 | $2.19 | 257,802 (Direct) | View |
| 2020-12-21 Exercise | 2020-12-21 4:53 pm | N/A 2028-12-12 | Stoke Therapeutics Inc. | STOK | Ticho Barry Chief Medical Officer | 1,365 | $0 | 257,802 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 9:08 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 50,000 | $0.6 | 352,757 (Direct) | View |
| 2020-12-17 Exercise | 2020-12-18 9:08 pm | N/A 2028-04-02 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 50,000 | $0 | 352,757 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-03 6:00 pm | N/A N/A | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $2.19 | 131,097 (Direct) | View |
| 2020-12-01 Exercise | 2020-12-03 6:00 pm | N/A 2018-12-12 | Stoke Therapeutics Inc. | STOK | Nash Huw M. COO | 5,700 | $0 | 131,097 (Direct) | View |